Join the FDA Inspection Preparedness & Compliance Online Training (May 7-8, 2025) to master regulatory inspection readiness for pharma, biotech, biologics, and medical device industries. This ...
DevOps and CSV form a powerful duo that, with strategic implementation, promises to propel the pharmaceutical industry.
FDA Inspection Seminar: Preparations for Pharmaceutical and Medical Device Professionals (ON-DEMAND)
The "FDA Inspection" training has been added to ResearchAndMarkets.com's offering. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no ...
FRANKFURT, March 9 (Reuters) - Europe should reduce its dependence on a small number of countries for vital drug supplies such as antibiotics and anaesthetics to boost the bloc's preparedness for ...
FLuID enables privacy-preserving knowledge sharing in drug discovery using knowledge distillation. The results show that the approach expands applicability domains and fosters collaboration across ...
A drug shortage is when a drug manufacturer isn't able to supply enough of a drug to meet all of its Canadian orders on time. The words drug, medication and medicine are often used interchangeably.
Orion GXP Consulting has built a strong team of good practice (GxP) audit professionals with decades of experience in GMP and GDP audits of global pharmaceutical drug substances, drug product ...
The Food and Drug Administration unexpectedly canceled an annual meeting of its advisers to update next season's influenza vaccines, an adviser on the panel and multiple officials tell CBS News ...
Weight loss drugs: Shortage of popular drugs Wegovy and Ozempic is over, FDA says Other sectors are also making manufacturing announcements. Earlier this week, Apple AAPL.O said it would spend ...
A March meeting of outside advisers to the US Food and Drug Administration to discuss the composition of flu vaccines for this fall’s flu season has been canceled, a member of the advisory ...
Drug compounders are taking legal action against the U.S. Food and Drug Administration, contesting the agency's recent decision to exclude Novo Nordisk's Wegovy and Ozempic from its drug shortage list ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results